A Comparison of Tumescence in Breast Reduction Surgery

• Status: Completed
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators' main hypothesis is that in breast reduction surgery, the use of tumescent solution containing both dilute lidocaine and epinephrine will lead to better control of postoperative pain, nausea, vomiting, shorter time through postoperative phases of care, quicker discharge from the hospital and lower numbers of hospital readmissions than the use of tumescent solution containing only dilute epinephrine.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Wisconsin, Madison
• Treatments: Epinephrine; Epinephryl borate; Lidocaine; Pharmaceutical Solutions; Racepinephrine

Criteria

Inclusion Criteria:

• all patients presenting for breast reduction surgery at the University of Wisconsin Hospital and Clinics and the University of Wisconsin Transformations Surgery Center and who do not meet any of the exclusion criteria.

Exclusion Criteria:

• Women under the age of 18 years

• Breast feeding or pregnant women

• Incarcerated women.

• Women unable to give consent because of impaired decision making ability.

• Women who have reported allergies to the substances that will be used in the study.